Patient and Healthcare Provider Resource

Patient and Healthcare Providers Resource

OralChemoEdSheets.com, Patient + Healthcare Providers Resource

OralChemoEdSheets.com, the Patient and Healthcare Providers Resource

Managing Nausea and Vomiting

Additional Resources
  • No Additional Resources

Nausea and vomiting can be a side effect of cancer treatment and may include having an upset stomach, feeling queasy, and vomiting.

 
Our Supplemental Sheet

This sheet is available to download as an Adobe PDF.

Get Managing Nausea and Vomiting Supplemental Sheet

 

NAUSEA AND VOMITING ORAL CHEMOTHERAPY EDUCATION Nausea and vomiting can be a side effect of cancer treatment and may include having an upset stomach, feeling queasy, and vomiting. To prevent nausea or to feel better, do the following: Eat 5 or 6 small meals during the day instead of 3 big meals. Eat before you get too hungry. An empty stomach can make nausea worse. Eat foods that are easy on the stomach, such as dry cereal, white toast, and crackers, without liquids first thing in the morning. Try lemon, lime, or other tart flavored foods. Sip on fluids throughout the day, like water, juice, broth, and semi flat soda. Avoid strong odors and smells. If you are vomiting, do the following: Stop eating. Once you stop vomiting, start back on food slowly, beginning with clear liquids, then try mild foods, such as gelatin, bananas, rice, and toast. Your doctor can prescribe medications to help relieve or lessen your nausea or vomiting. Take your medication as directed by your doctor or nurse. Take your anti nausea medicine as soon as you start to feel nauseous. This is the best way to prevent vomiting. Sometimes you can take more than 1 medication to prevent or treat nausea. If needed, you can take these medications on a consistent schedule or 30 minutes before taking your cancer treatment to better control nausea. Call your care team if you experience any of the following symptoms: The anti nausea medicine you are taking is not working and you are experiencing nausea or vomiting. You are unable to drink fluids for more than 1 day due to ongoing nausea or vomiting. Important notice: The Association of Community Cancer Centers (ACCC), Hematology/Oncology Pharmacy Association (HOPA), National Community Oncology Dispensing Association, Inc. (NCODA), and Oncology Nursing Society (ONS) have collaborated in gathering information for and developing this patient educational supplement. This summarized information represents a brief summary of supportive care information and other resources. This supplement does not cover all existing information related to the possible directions, doses, precautions, interactions, adverse effects, or risks associated with specific medication or adverse events and should not substitute for the advice of a qualified healthcare professional. Provision of this supplement is for informational purposes only and does not constitute or imply endorsement, recommendation, or favoring of this side effect management by ACCC, HOPA, NCODA, or ONS, who assume no liability for and cannot ensure the accuracy of the information presented. The collaborators are not making any representations with respect to the clinical information presented whatsoever, and any and all decisions, with respect to such patient management, are at the sole risk of the individual consuming the medication. All decisions related to education and managing adverse events should be made with the guidance and under the direction of a qualified healthcare professional. Permission: Supplemental Oral Chemotherapy Education (OCE) sheets are provided as a free educational resource for patients with cancer in need of concise, easy to understand information about cancer topics and adverse event management. Healthcare providers are permitted to copy and distribute the sheets to patients as well as direct patients to the OCE website for information. However, commercial reproduction or reuse, as well as rebranding or reposting of any type, are strictly prohibited without permission of the copyright holder. Please email permission requests and licensing inquiries to This email address is being protected from spambots. You need JavaScript enabled to view it.. Copyright © 2020. All rights reserved.FEDRATINIB ORAL CHEMOTHERAPY EDUCATION NAUSEA AND VOMITING ORAL CHEMOTHERAPY EDUCATION Additional instructions Important notice: The Association of Community Cancer Centers (ACCC), Hematology/Oncology Pharmacy Association (HOPA), National Community Oncology Dispensing Association, Inc. (NCODA), and Oncology Nursing Society (ONS) have collaborated in gathering information for and developing this patient educational supplement. This summarized information represents a brief summary of supportive care information and other resources. This supplement does not cover all existing information related to the possible directions, doses, precautions, interactions, adverse effects, or risks associated with specific medication or adverse events and should not substitute for the advice of a qualified healthcare professional. Provision of this supplement is for informational purposes only and does not constitute or imply endorsement, recommendation, or favoring of this side effect management by ACCC, HOPA, NCODA, or ONS, who assume no liability for and cannot ensure the accuracy of the information presented. The collaborators are not making any representations with respect to the clinical information presented whatsoever, and any and all decisions, with respect to such patient management, are at the sole risk of the individual consuming the medication. All decisions related to education and managing adverse events should be made with the guidance and under the direction of a qualified healthcare professional. Permission: Supplemental Oral Chemotherapy Education (OCE) sheets are provided as a free educational resource for patients with cancer in need of concise, easy to understand information about cancer topics and adverse event management. Healthcare providers are permitted to copy and distribute the sheets to patients as well as direct patients to the OCE website for information. However, commercial reproduction or reuse, as well as rebranding or reposting of any type, are strictly prohibited without permission of the copyright holder. Please email permission requests and licensing inquiries to This email address is being protected from spambots. You need JavaScript enabled to view it.. Copyright © 2020. All rights reserved

Our Foundation Sponsors

Boehringer_Ingelheim
Takeda Oncology
BeiGene
 

Our Sustaining Sponsors